• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

90
65
62
45
44

COUNTRY

22
17
17
15
14

CATEGORIES

  • 205
  • 118
  • 44
  • 32
  • 17
  • 16
  • 11
  • 9
  • 6
  • 6
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

78
87
233
392

PUBLISHED

2
22
98
392

PRODUCT TYPE

312
80

Search "Eli Lilly and Company - SWOT Analysis" returned 392 results.

Eli Lilly & Co. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Eli Lilly & Co. Company Profile” is a comprehensive report on Eli Lilly & Co.. The report provides complete information on the operations, organization structure and financial information details of...

October 2014
FROM

Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review

Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2015
FROM

Eli Lilly and Company - SWOT Framework Analysis

SWOT Analysis, is a strategic planning tool used to evaluate the Strengths, Weaknesses, Opportunities, and Threats involved in a project or in a business venture. It involves specifying the objective...

April 2013
FROM

Eli Lilly and Company - Strategy and SWOT Report

Eli Lilly and Company - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service...

March 2015
FROM

Eli Lilly and Company - SWOT, Strategy and Corporate Finance Report

Eli Lilly and Company - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product...

January 2013
FROM

Global Oncology/Cancer Drugs Market (Therapeutic Modalities, Cancer Types and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer...

February 2015
FROM

Global Acute Coronary Syndrome (ACS) Market 2015-2019

About ACS ACS is a condition that results in sudden and reduced blood flow to the heart. ACS is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations,...

March 2015
FROM

PharmaPoint: Neuropathic Pain - Current and Future Players

PharmaPoint: Neuropathic Pain - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Neuropathic Pain - Current and Future Players”. The report is a vital source...

April 2014
FROM

PharmaPoint: Microvascular Complications of Diabetes - Current and Future Players

PharmaPoint: Microvascular Complications of Diabetes - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Microvascular Complications of Diabetes - Current...

December 2013
FROM

PharmaPoint: Colorectal Cancer - Current and Future Players

PharmaPoint: Colorectal Cancer - Current and Future Players Summary The publisher has released its pharma report, “PharmaPoint: Colorectal Cancer - Current and Future Players”. The report is a vital...

November 2014
FROM

PharmaPoint: Alzheimer's Disease - Current and Future Players

PharmaPoint: Alzheimer's Disease - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Alzheimer's Disease - Current and Future Players” The report is a vital...

July 2013
FROM

Global Osteoporosis Drugs Market 2015-2019

About osteoporosis Osteoporosis, or porous bone, is a disease characterized by low bone density and structural deterioration of bone tissue, leading to fragile bones. As bones becomes fragile, risk...

May 2015
FROM

Analysis of Eli Lilly and Company

Analysis of Eli Lilly and Company. A complete and comprehensive analysis of Eli Lilly and Company, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry,...

January 2013
FROM

Global Anxiety Disorders Market 2015-2019

About Anxiety Disorders Anxiety is associated with uneasiness, fearfulness, and tension. Mild anxiety, for example, associated with exams or interview, is normal and triggers 'fight or flight' response....

January 2015
FROM

PharmaPoint: Schizophrenia - Current and Future Players

PharmaPoint: Schizophrenia - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Schizophrenia - Current and Future Players”. The report is a vital source of...

February 2014
FROM

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances,...

June 2014
FROM

Global and Chinese Insulin Industry Report 2014

The Global and Chinese Insulin Industry Report 2014 is a professional and in-depth study on the current state of the global insulin industry with a focus on the Chinese situation The report provides...

April 2014
FROM

Global Erectile Dysfunction Drugs Market 2014-2018

About Erectile Dysfunction Drugs A man's failure to sustain an erection that is adequate enough for sexual activity is known as erectile dysfunction. It also refers to the inconsistency to do so, or...

September 2014
FROM

Global Recombinant Human Insulin Industry Report 2015

The Recombinant Human Insulin industry Report 2015 is a professional and in-depth study on the current state of the Recombinant Human Insulin Industry with a focus on the Chinese situation. The report...

January 2015
FROM

PharmaPoint: Rheumatoid Arthritis - Current and Future Players

PharmaPoint: Rheumatoid Arthritis - Current and Future Players Summary The publisher has released its pharma report, “PharmaPoint: Rheumatoid Arthritis - Current and Future Players”. The report is...

December 2014
FROM
Loading Indicator

Our Clients

Credit Suisse Group Heinz Company Telenor Group Deutsche Bank AG Solvay S.A. APC by Schneider Electric Lindt & Sprüngli AG